TNF-beta产品信息
英文名称:Tumor necrosis factor β
中文名称:肿瘤坏死因子β
靶点别称:TNF-beta,Lymphotoxin-alpha
物种:Human
属性:Protein
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![1.jpg 1.jpg](/SupplyImg1/2024-05-27/6385242722536542679133119.jpg)
TNF-beta分子背景
TNF-beta是肿瘤坏死因子家族的成员,是淋巴细胞产生的细胞因子。该蛋白质具有高度的诱导性、分泌性,并与淋巴毒素β形成异三聚体,将淋巴毒素α锚定在细胞表面。该蛋白还介导多种炎症、免疫刺激和抗病毒反应,参与发育过程中次级淋巴器官的形成,并在细胞凋亡中发挥作用。该基因的遗传变异与麻风病4型、心肌梗死、非霍奇金淋巴瘤和银屑病关节炎的易感性有关。或者,已经观察到该基因的剪接转录变体。
![通用.jpg 通用.jpg](/SupplyImg1/2024-05-27/6385242723441128456364186.jpg)
关键字: TNFB蛋白;TNF-beta;TNF-beta蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。